跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ascorsaph-Na - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ascorsaph-Na
Approved
STANDARD
Ascorsaph-Na
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8756fee8c2713aea
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
8756fee8c2713aea
Drug Approval Philippines Name
Ascorsaph-Na
Product Name
Ascorsaph-Na
Registration Number
DRP-8937
Brand Name
Ascorsaph-Na
Generic Name
Ascorbic Acid
Dosage Form
Capsule
Dosage Strength
500mg (Equi. To 562.50mg Sodium Ascorbate)
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
27 April 2025
Expiry Date
01 July 2031
Pharmacologic Category
Vitamin
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8756fee8c2713aea
Type
Standard
Back to Philippines FDA Approvals